Caldan, a spin-out company from the Universities of Glasgow and Southern Denmark, is developing novel therapeutics targeting free fatty acid receptors for NASH, Type 2 Diabetes (T2D) and other potential indications. Caldan has arisen from a long-term collaboration between Professor Trond Ulven at the University of Southern Denmark and Professor Graeme Milligan of the University of Glasgow.
View Top Employees from Caldan Therapeutics| Website | http://www.caldantherapeutics.co.uk |
| Revenue | $5 million |
| Employees | 5 (2 on RocketReach) |
| Founded | 2015 |
| Phone | +44 7701 067727 |
| Industry | Biotechnology Research, Business Services General, Business Services |
| Web Rank | 19 Million |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Caldan Therapeutics employee's phone or email?
Caldan Therapeutics Questions
The Caldan Therapeutics annual revenue was $5 million in 2024.
2 people are employed at Caldan Therapeutics.
Caldan Therapeutics is based in Edinburgh, Scotland.
The NAICS codes for Caldan Therapeutics are [541714, 541, 5417, 54, 54171].
The SIC codes for Caldan Therapeutics are [873, 87].
Top Caldan Therapeutics Employees
-
25+
Related Companies
